Skip to main content

Around 10% of the worldwide population was affected by chronic kidney disease fostering growth of the medical membrane market

 


The growing prevalence of infectious chronic diseases such as chronic kidney disease around the globe is augmenting the growth of the medical membrane market. According to the National Kidney Foundation 2018, data around 10% of the worldwide population was affected by chronic kidney disease. Moreover, growing government initiatives in research and development, development in the healthcare industry, pharmaceutical, biotechnology industry, and rising adoption of medical membranes across several industries are major factors propelling the growth of the medical membrane market. On the other hand, high capital investment for the production of membrane and surface fouling is estimated to restrict the growth of the market.

The key players operating in the global medical membrane market include Nipro Corporation, Amniox, Pall Corporation, Sorin Group, Gore, Maquet Company, Merck Millipore, and others

In November 2018, Merck, the vibrant science and technology company launched its new BioContinuum™ Platform to advance biotherapeutic drug manufacturing through improved efficiency, simplified plant operations, and greater quality and consistency

North America is expected to exhibit significant growth over the forecast period and this is attributed to the high prevalence of chronic disease in the region. According to the National Health Council, chronic diseases affect approximately 133 million Americans, representing more than 40% of the total population of this country.2 By 2020, that number is projected to grow to an estimated 157 million, with 81 million having multiple conditions. Moreover, growing initiatives by the government to reduce the mortality associated with kidney disease are also projected to foster the growth of the market. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), aims to reduce the mortality and morbidity linked with kidney disease by introducing the initiative National Kidney Disease Education Program.

Medical membranes are manufactured for use in separation processes across the medical industry for use in various applications. They provide high-speed filtration of microorganisms, fungi, and other particles in aqueous solutions to filter out microorganisms, bacteria, and viruses. In addition, medical membranes are widely used in pre-filtration, pretest, analytical method development, dry cell filtering, dilution, analytical method development, dilutive dialysis, sorption, electrodialysis, capillary free flow, submicron filtration, and expression method development. They are also commonly used to cleanse the air, for mechanical ventilation and environmental cleanliness purposes. Medical membranes can be made of vinyl, polyvinyl chloride, polypropylene, ethylene, or other membranes commonly used in many industries.

 

Comments

Popular posts from this blog

The Global Autoclave Equipment Market Continues To Grow Owing To the Rising Demand from Healthcare Sectors for Sterilizing Medical Equipment to Ensure the Safety of the Post-Surgical Period

  Autoclave equipment is the most popular sterilization method in the industry and is used for many applications including the manufacture of food products. It is widely used in the foodservice industry to sterilize and cleanse equipment used in the process of preparing and serving food. The autoclave is the abbreviated form of autolysis which means oxidation. Autoclaves have various parts including an electric motor, a condenser, and a burner. Autoclave equipment includes vials for sealing the autoclave, a glass or plastic container that has been lined with wax or plastic, and the appropriate autoclave equipment accessories such thermometer for measuring the temperature of the autoclave. All modern steam sterilizing equipment & autoclave machines provide a much-refined workflow experience, which makes you reconsider whether or not steam sterilizing is all it can be. A wide range of sterilization methods is used for sterilizing your medical and laboratory specimen so the right ...

Biologics Market Increasing Prevalence of Chronic Diseases to Augment Growth of the market

  A  biologic  drug ( biologics ) is a product that is produced from living organisms or contains components of living organisms.  Biologic  drugs are widely used to prevent, diagnose, treat, or cure a variety of diseases, including infectious diseases, autoimmune disorders, chronic kidney disease, and cancer. Market Dynamics In the recent past, several novel biopharmaceutical products were approved by major regulatory bodies and major players in the market have launched various novel and innovative biopharmaceutical products. Rapid approvals and launches of novel products in the market are expected to be major drivers for growth of the biologicsmarket . 

Treprostinil Drugs Market - High Prevalence of Pulmonary Arterial Hypertension and R&D of New Formulations of Treprostinil to Augment Growth of market

  Treprostinil is an antihypertensive agent used to treat patients with pulmonary arterial hypertension. It can also be used in the treatment of Degos disease, an extremely rare disorder in which small and medium sized arteries become blocked (occlusive arteriopathy), restricting the flow of blood to affected areas. Market Dynamics High prevalence of pulmonary arterial hypertension is expected to propel growth of the treprostinil drugs market . For instance, according to the study, ‘High Geographic Prevalence of Pulmonary Artery Hypertension: Associations with Ethnicity, Drug Use, and Altitude’, published in February 2020, in the journal Pulmonary Circulation, the overall pulmonary arterial hypertension incidence was 14 cases per million and the annual period prevalence of pulmonary arterial hypertension was 93 cases per million. Decline in new prescriptions for treprostinil-based products is expected to hinder growth of the treprostinil drugs market. For instance, United The...